Neuren Pharmaceuticals reported AUD134.03M in Net Income for its fiscal semester ending in December of 2024.


Net Income Change Date
Alaunos Therapeutics USD -742000 385K Dec/2024
Avita Medical AUD -11589000 3.8M Dec/2024
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Genetic Signatures AUD -15200000 7.81M Dec/2024
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
Medical Developments International AUD 304K 15.32M Dec/2024
Neuren Pharmaceuticals AUD 134.03M 126.01M Dec/2024
Organon & Co USD 145M 58M Jun/2025
Paradigm Biopharmaceuticals AUD -5924050 3.77M Dec/2024
PYC Therapeutics AUD -25572620 14.25M Dec/2024
Starpharma Holdings AUD -5392000 1.82M Dec/2024
Tectonic Therapeutic USD -19980000 7.61M Jun/2025
Telix Pharmaceuticals AUD 10.13M 19.52M Dec/2024
Viatris USD -4600000 3.04B Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025